Because primary TF engagement cannot be adequately dissected by using endogenous systems that already express FOXA2 as part of their regulatory circuitry, we engineered a doxycycline (DOX)-inducible system in immortalized foreskin fibroblasts (BJ), which do not normally express FOXA2 or other FOXA family members ( Supplementary Fig. 1d ). We derived several clonal cell lines Supplementary  Fig. 1a,b ) mapped across the genome that were unbound or bound by FOXA2 in HepG2, A549 and dEN cells. b, Read-density heat maps (normalized read count) for statistically called FOXA2 peaks in HepG2, A549 and dEN cells that overlapped a motif instance. 2 kb on each side of the peaks are shown. Heat maps are clustered according to the occurrence of binding across the three cell types. Genome-browser tracks from left to right highlight genomic occupancy across the three cell types: shared (chromosome (chr) 18: 9072728-9075158), unique in HepG2 (chr 18: 9202880-9225100), unique in A549 (chr18: 9008450-9022842), shared in A549 and HepG2 (chr 18: 8725886-8734843), shared in HepG2 and dEN (chr 4: 80986601-81000201), shared in A549 and dEN (chr 4: 75017694-75029960) and unique in dEN (chr 4: 74903404-74905306). c, Schematic of the pTripZ vector used for the generation of clonal FOXA2-inducible (BJ FOXA2 ) cell lines. Cropped western blots of FOXA2 and H3 protein levels in two distinct BJ FOXA2 clones. d, Browser tracks displaying differential binding across ectopic BJ FOXA2 and dEN (chr 18: 19745852-19782939) . FOXA2 FPKM values are shown at right. Below the scatter plot, output of DiffBind 42 differential peak-set analysis between dEN and BJ FOXA2 is shown. Red dots, peaks with statistically significant differential enrichment between the two datasets. Axes are reads per kilobase of transcript per million mapped reads (RPKM (referred to as BJ FOXA2 ) with no detectable FOXA2 in the uninduced state but rapid, uniform and consistent mRNA/protein induction after DOX treatment ( Fig. 1c and Supplementary Fig. 1e -g) and performed ChIP-seq for FOXA2 after 1, 4 and 10 d of induction. We observed a clear increase in FOXA2 binding between 1 and 4 d but little change afterward ( Supplementary Fig. 1h ,i and Supplementary  Table 1 ) and identified a total of 49,830 consensus peaks for the combined 4-and 10-d time points, of which 98% contained a FOX family motif 21 ( Supplementary Fig. 1j ). Despite supraphysiological levels, we still primarily observed cell-type-specific FOXA2 binding: ~ 70% of FOXA2 peaks showed differential enrichment between dEN and BJ FOXA2 (Fig. 1d ). Therefore, DNA sequence alone is clearly insufficient to direct binding, because many potential FOXA2 targets remained unbound in ectopic conditions.
FOXA2 and GATA4 demonstrate low-level sampling at many of their alternative lineage targets. Although we observed only a partial overlap between significantly called FOXA2 peaks in endogenous and ectopic contexts, we nevertheless noticed consistent lowlevel FOXA2 enrichment in BJ FOXA2 at most regions that are highly occupied in dEN, HepG2 and A549 cells ( Fig. 1e and Supplementary  Fig. 2a ). Within the union set of previously defined endogenous and ectopic peaks, a notable number of statistically unoccupied regions still displayed low to intermediate FOXA2 enrichment, as compared to the genomic background ( Fig. 1g ). To determine whether this low-level enrichment was a general feature of ectopic TF expression, we engineered inducible BJ fibroblasts for two other presumed pioneer TFs, OCT4 and GATA4 (BJ OCT4 and BJ GATA4 ; Supplementary Fig. 2b and Supplementary Tables 2 and 3 ) and found a comparable low-level enrichment for GATA4 but not for OCT4 ( Fig. 1f,g) . However, ectopic OCT4 has been shown to display low-level enrichment at ESC OCT4 targets when it is coexpressed with SOX2, KLF4 and cMYC in BJ fibroblasts 5 , indicating that this ability is context and cofactor dependent ( Supplementary Fig. 2c ). GATA4 and BJ OCT4 with assigned chromatin states, which were defined hierarchically in BJ before TF induction. First, 'accessible' regions were categorized by ATAC-seq enrichment. Then regions highly enriched in H3K27ac or H3K4me1 were categorized as 'active' or 'poised', respectively. Regions enriched in H3K27me3 or H3K9me3 were categorized broadly as 'repressed'. Finally, all remaining regions were grouped on the basis of their DNAme levels: highly methylated regions (HMRs, >60% mean methylation), intermediately methylated regions (IMRs, 20-60% mean methylation) and lowly methylated regions (LMRs, <20% mean methylation). LMRs are a 'low signal' state that lacks DNA accessibility as well as enrichment of any assessed histone modifications 4 . b, Spearman correlations between TF enrichment for peak sets as described in Fig. 1g and epigenetic features, displayed as a heat map. c, Scatter plots and LOWESS fit curves (green line) of FOXA2, GATA4 and OCT4 versus ATAC-seq enrichment in BJ before TF induction. d, Pie charts summarizing the percentage of FOXA2 and OCT4 targets that overlapped defined preexisting closed chromatin and were located within or outside of annotated CGIs. e, Representative genome-browser tracks displaying FOXA2 and OCT4 enrichment compared with preinduced BJ ATAC-seq data (chr 5: 140657329-141085891). Purple box highlights regions of OCT4 binding in preexisting closed chromatin that overlapped annotated CGIs. Gray boxes highlight FOXA2 binding at preexisting closed chromatin, and blue boxes highlight OCT4 binding in regions of preexisting open chromatin.
Additionally, we found that this low-level enrichment was also present in cells endogenously expressing FOXA2 and therefore is not just a product of ectopic or supraphysiological expression ( Supplementary Fig. 2d ,e).
Influence of prior epigenetic state on FOXA2, GATA4 and OCT4 binding.
To determine how a cell's preexisting epigenome might affect pioneer-factor binding, we performed ChIP-seq for select histone modifications associated with active (acetylated histone H3 K27 (H3K27ac) and monomethylated H3 K4 (H3K4me1)) and repressive (trimethylated H3 K27 (H3K27me3)) states, assay for transposon-accessible chromatin (ATAC-seq) 22 for DNA accessibility and whole-genome bisulfite sequencing (WGBS) for DNA methylation (DNAme) levels (Supplementary Table 4 ). We then defined chromatin states by using simple hierarchical rules reflecting prior knowledge of these modifications and how they interact ( Supplementary Fig. 3a ). For this analysis, we focused on the most highly enriched targets in a given cell type and found that ectopic FOXA2 and GATA4 predominantly engaged sites that are devoid of the selected histone modifications and contain variable DNAme levels ( Fig. 2a ). Endogenous FOXA2 displayed a similar behavior in undifferentiated ESCs at sites that are bound by FOXA2 in dEN ( Supplementary Fig. 3b ). There was little correlation between FOXA2 or GATA4 enrichment and selected epigenetic features, yet OCT4 binding was positively correlated with preexisting accessible chromatin ( Fig. 2a-c and Supplementary Fig. 3b ) and frequently overlapped with CpG islands (CGIs) (Fig. 2d ,e and Supplementary Fig. 3c ). To compare these behaviors to the ectopic binding of a presumed nonpioneer factor, we generated another BJ line expressing hepatocyte nuclear factor 1A (HNF1A). We observed no significant HNF1A binding when expressed alone, but enrichment became readily detectable in combination with FOXA2 ( Supplementary  Fig. 3d-f ). Finally, FOXA2 enrichment was generally depleted in H3K9me3 heterochromatin domains 5 ( Supplementary Fig. 3g -i). However, few endogenously occupied FOXA2 regions reside within these domains, which are therefore unlikely to be the major cause of the cell-type-specific occupancy ( Supplementary Fig. 3j ).
GATA4 coexpression increases FOXA2 enrichment at a subset of previously sampled targets.
Given the limited ability of the epigenome to determine FOXA2 binding, we speculated that occupancy might instead be directed primarily through cooperativity with celltype-specific cofactors, as is common among nonpioneer TFs 1, 23 and has recently also been suggested for some pioneer TFs 12, 13 . To identify potential cofactors, we searched for differentially enriched motifs between regions bound by FOXA2 exclusively in dEN or BJ FOXA2 and cross-referenced those motifs against RNA-seq data for the corresponding expressed TFs ( Fig. 3a and Supplementary  Fig. 4a ). Motif sequences for several known endodermal regulators were enriched at dEN-exclusive sites, including GATA4, which is known to bind to the ALB enhancer locus with FOXA2 in early gut endoderm cells prior to ALB expression [24] [25] [26] . Thus, we selected GATA4 as a candidate cofactor that might influence FOXA2 binding in the ectopic system. Using our previously published data 27 for FOXA2 and GATA4 binding in dEN, we found that the two factors colocalize at 2,364 genomic sites, 2,093 of which overlap with FOXA2 dEN-exclusive targets ( Supplementary Fig. 4b ). We infected BJ FOXA2 with a second lentiviral construct containing constitutively expressed V5-tagged GATA4, induced simultaneous expression of both factors for 4 d and performed ChIP-seq for FOXA2 ( Fig. 3b ; BJ FOXA2-GATA4 ). We found that a specific subset of targets (504 of 2,093) displayed a substantial increase upon GATA4 coexpression (referred to as 'GATA4 stabilized'; Fig. 3c-f ). Intriguingly, the majority of the GATA4-stabilized sites show evidence of low enrichment sampling when either FOXA2 or GATA4 are induced alone ( Fig. 3e and Supplementary Fig. 4c ). Ultimately, coexpression could explain only a subset of the dEN-exclusive cobound FOXA2 targets. When we searched for additional confounding factors, we found that the GATA motif was differentially enriched in the GATA4-stabilized subset compared with the nonenriched subset (P = 1.0 × 10 −5 ; motif occurring at 76% of regions). In addition, we observed weak differential enrichment of other endodermal-TF motifs at regions where GATA4 did not stabilize FOXA2 binding (T box, P = 1.0 × 10 −3 ; Eomes, P = 1.0 × 10 −3 ; SOX, P = 1.0 × 10 −3 ), suggesting that FOXA2 occupancy at these regions may be dependent on multiple TFs. In general, we found that FOXA2 binding at GATA4-stabilized targets did not appreciably increase chromatin accessibility, which indicates that the recruitment of additional chromatin-remodeling machinery had probably not yet occurred ( Supplementary Fig. 4d ). Instead, cooperative pioneer-TF activity appears to assist in loading to nucleosomal DNA and not nucleosome eviction. Collectively, our data support a model wherein pioneer-factor occupancy is genetically encoded and partially determined by cofactor engagement at specific subsets of target loci.
Transcriptional and epigenetic effects of ectopic FOXA2 binding.
To determine the molecular effects of ectopic TF binding, we performed RNA-seq, ATAC-seq and ChIP-seq 48 h after FOXA2 induction. In line with results from previous studies on pioneer factors 7, 18 , we found only a small number of genes that were immediately responsive to induction (299 genes upregulated and 191 genes downregulated) with only 82 genes directly associated with promoter-proximal FOXA2 binding (±1 kb from the TSS; Supplementary Fig. 5a and Supplementary Table 5 ). Because of the limited transactivating properties, we focused on chromatin changes after FOXA2 occupancy and found many regions that either acquired de novo or exhibited increased H3K4me1, dimethylated H3 K4 (H3K4me2) and H3K27ac after FOXA2 induction ( Supplementary Fig. 5b ). De novo H3K4 methylation following FOXA factor occupancy has previously been observed to establish competency at cis-regulatory regions 7, [28] [29] [30] . Additionally, we found that 1,937 of 4,962 de novo H3K4me2 regions concomitantly gained low enrichment of H3K27ac as well.
Next, we focused on FOXA2-occupied regions within preexisting closed chromatin and measured induced changes to DNA accessibility and histone modification. Occupancy alone appeared to be insufficient to affect global accessibility, because only a fraction (~ 13%) of BJ FOXA2 targets demonstrated significant gains in ATAC-seq signal ( Fig. 4a,b ; n = 2,092 of 15,888, P ≤ 2.2 × 10 −16 ). Despite the infrequent increase in DNA accessibility in BJ FOXA2 , 61% of unchanged targets (5,144 of 8,443) overlapped with putative generegulatory elements that are accessible in at least one other cell type, on the basis of all available ENCODE DNase-hypersensitivity data 31 . However, we detected some low-level increases in ATAC-seq signal even at the target sites that remained inaccessible on the basis of our thresholds ( Fig. 4c and Supplementary Fig. 5c ). We identified a number of distinguishing features that characterized sites that significantly gained accessibility from those that did not. First, FOXA motifs were more highly enriched and widely distributed across the region ( Supplementary Fig. 5d-f ). Second, the mean ATAC-seq signal prior to FOXA2 induction was slightly higher ( Supplementary  Fig. 5g ). Third, after FOXA2 induction, we observed enrichment in phased nucleosomes modified by H3K4me1/me2 and H3K27ac surrounding the FOXA2 peak summit (Fig. 4d ). Scatter plots of binned ATAC-seq signal compared with histone-modification enrichment demonstrated a somewhat linear relationship between gain in DNA accessibility and gain in H3K4me1 (along with a weaker enrichment and correlation for H3K4me2 and H3K27ac; Supplementary  Fig. 5h ). However, the enrichment of activating histone modifications at these regions was quite modest and did not reach enrichment levels similar to those seen for active promoters, for example ( Supplementary Fig. 5i ). Furthermore, we observed that most of the ATAC-seq signal gained after FOXA2 occupancy was lost within 2 d of factor withdrawal, indicating the transient behavior of this remodeling, in agreement with prior work 3 ( Supplementary Fig. 5c,j) .
DNA methylation dynamics at FOXA2 targets. We next investigated FOXA2-mediated demethylation in BJ FOXA2 , because it has been shown to be associated with loss of methylation at target FOXA2 enrichment as well as CpG methylation levels prior to and after induction. Top, example of a class 2 region located at chr 12: 54002592-54021127. Bottom, an example of a class 3 region located at chr 18: 32911411-32941267. Zoomed views display CpG locations within the peak. c, Violin plot of CpG density of class 2 and class 3 target sites. CpG density was calculated as the number of CpG dinucleotides across 100-bp windows divided by the total number of base pairs. Dots, median values; black lines, interquartile ranges. d, Composite plots showing normalized CpG counts of class 2 and class 3 target sites (left). Class 2 was depleted in CpGs toward the center of the peak, whereas class 3 targets were enriched. The mean sequencing coverage between class 2 and class 3 target sites was equivalent (right). e, CpG-methylation box plots of 20-bp windows from the peak summit and extended to 200 bp. Methylation measurements were taken from ChIP-BS-seq data. Class 2, black; class 3-1, blue. Boxes indicate interquartile range, and whiskers show maximum and minimum values. Horizontal lines, medians. sites 18, 29 . To quantify DNAme levels on fragments that were physically associated with FOXA2, we performed chromatin immunoprecipitation followed by bisulfite sequencing (ChIP-BS-seq) 32 after 4-d induction and compared methylation levels with those from WGBS data from preinduced cells ( Supplementary Table 6 ). We found that FOXA2 occupied three distinct sets of genomic regions: those in preexisting lowly methylated DNA that remained as such after FOXA2 binding ( Fig. 5a ; class 1, n = 16,742); those that displayed high DNAme levels before and after FOXA2 binding ( Fig. 5a,b ; class 2, n = 8,794); and a unique class of regions displaying a clear loss of DNAme after FOXA2 binding (≥20% change, Fig. 5a reproducible even when the N-or C-terminal domain of FOXA2 was deleted, indicating that neither domain was responsible for the local demethylation observed at class 3 targets ( Supplementary Fig. 6 ).
Because of the unexpected heterogeneity in response to FOXA2 binding, we scrutinized the differences between class 2 and 3 target sites in further detail. First, we confirmed the interaction between DNAme and FOXA2 by using in vitro electromobility shift assays (EMSAs) and found no preference for methylated, hemimethylated or unmethylated DNA ( Supplementary Fig. 7a,b) . We next selected a stringent subset of class 3 targets with high methylation (≥80%) in uninduced BJ FOXA2 cells (Fig. 5a ; class 3-1, n = 5,253) to be more comparable to the mean methylation of class 2 targets (≥80%). Importantly, FOXA2 enrichment did not correlate with changes in DNAme levels at class 3-1 targets ( Supplementary Fig. 7c ), and both class 2 and class 3-1 target loci were largely indistinguishable in their genomic location and CpG density ( Fig. 5c ; mean CpG count 4.2 and 4.8 for class 2 and 3-1, respectively). However, after closer inspection, we found that the class 2 targets were comparatively depleted of CpG dinucleotides toward the peak summit (Fig. 5d) . Additionally, the distance from the peak summit to the nearest CpG was significantly greater for class 2 versus class 3-1 targets (average 74 bp and 90 bp, respectively; P ≤ 2.2 × 10 −16 ), whereas the average methylation for these nearest CpGs prior to FOXA2 induction was indistinguishable ( Supplementary Fig. 7d-f ; P = 0.95, average 95% methylated in both). Of note, the change in CpG methylation is greatest toward the peak summit ( Fig. 5e and Supplementary Fig. 7g ), a result that, together with the limited observed chromatin dynamics ( Supplementary Fig. 7h,i) , suggests that loss of DNAme is unlikely to be a result of recruited histone-modifying enzymes and may be physically linked to FOXA2 occupancy.
Loss of DNAme depends on DNA replication.
The transition from a methylated to an unmethylated base may require an active enzymatic removal of the methyl group 33 , a passive replication-dependent loss (which would require blocking any maintenance activity after nascent-DNA synthesis) or a combination of both 34, 35 . To investigate this mechanism as it occurs for class 3 targets, we used mimosine treatment to reversibly halt BJ FOXA2 cells in G 1 before DNA replication, then induced FOXA2. We subsequently either continued mimosine treatment or restored cell-cycle progression (as verified by 5-ethynyl-2′-deoxyuridine (EdU) incorporation) for approximately one to two rounds of cell division ( Supplementary Fig. 8a ). We then collected the cells and performed FOXA2 ChIP-BS-seq ( Fig. 6a and Supplementary Tables 7 and 8 ). Notably, FOXA2 occupied similar genomic regions in both conditions, indicating that it can access these loci even in arrested cells ( Fig. 6b and Supplementary Fig. 8b ). Quite strikingly, arrested cells displayed no measurable decrease in DNAme levels at FOXA2-occupied regions, despite changes to DNA accessibility (Fig. 6c,d) . Together, these results highlight that FOXA2 binding and its effects on DNA accessibility are replication independent, whereas loss of DNAme is replication dependent. Mechanistically, we hypothesized that the immediate recruitment of FOXA2 to target regions after DNA replication (S phase) might be sufficient to block maintenance methylation by DNMT1. To explore this possibility, we generated BJ fibroblasts expressing FOXA2 fused to CDT1 (ref. 36 ) (BJ FOXA2-CDT1 ) to specifically deplete FOXA2 expression during S phase (Fig. 6e ). FOXA2 protein levels were higher in G 1 compared with G 2 -M phases, although the presense of residual protein was still observed, possibly as a result of the supraphysiological expression ( Fig. 6e ). To ensure similar targetsite enrichment of FOXA2 in this new system, we performed ChIPseq in G 1 -arrested BJ FOXA2-CDT1 cells, in which FOXA2 protein levels were most similar to those in BJ FOXA2 , and observed high correlation compared with either arrested or released BJ FOXA2 ( Supplementary  Fig. 8c,d) . We then induced FOXA2 for 4 d, performed ChIP-BS-seq in normal cycling conditions, and observed substantially reduced loss of DNAme at class 3-1 targets ( Fig. 6f and Supplementary Fig.  8e,f) . Together, our results suggest that FOXA2 occupancy in S phase may be necessary to facilitate targeted loss of DNA methylation.
Discussion
Here, we compiled a set of cis-regulatory elements that are occupied by FOXA2 in endogenously expressing cell types (HepG2, A549 and dEN) and established that ectopic expression in BJ fibroblasts did not recapitulate the high enrichment occupancy at most of these endogenous targets, despite supraphysiological expression. Instead, we observed a minimal overlap between endogenous and ectopic datasets but observed broad low-level enrichment (sampling) for most regions that are occupied by FOXA2 in alternative lineages and cell lines. Sampling may occur as a result of slow chromatin scanning of pioneer factors 37 , yet recent evidence from single-molecule-tracking studies suggests that pioneer factors may actually have rapid DNA-residence times that are similar to those of nonpioneer TFs 12 . From these experiments, it is not possible to distinguish whether sampled sites were bound with high frequency/stability in a small number of cells or whether more transient binding occurred at these regions within all cells, because standard ChIP-seq signals are averaged across populations. Future application of competition ChIP experiments or similar approaches might yield further insight.
Nevertheless, sampling appears to be a distinctive characteristic of FOXA2 and GATA4, as OCT4 predominantly exhibited highly enriched cell-type-specific occupancy. This result is consistent with findings from a recent study showing that mouse OCT4 also occupies distinct genomic regions when it is expressed alone or with other reprogramming factors 38 . Notably, the same study has found that, when induced alone, OCT4 primarily occupies regions of preexisting open chromatin 38 . Sampling of alternative target sites may therefore be a defining pioneer-TF quality that factors such as OCT4 acquire within only specific cellular contexts or in combination with additional factors.
We find that cell-type specific binding is most strongly influenced by the presence of additional cofactors, which stabilize FOXA2 at regions that are otherwise only sampled. Modest changes in pioneerfactor occupancy due to cofactor expression have also recently been observed by others 12, 13 . The cooperativity that we observed between FOXA2 and GATA4 at this specific subset of target sites appears to be distinct from the dynamic assisted-loading model of TF binding 12,23 , because we found little change in DNA accessibility by using ATAC-seq when these regions are cooccupied. Because GATA4 coexpression stabilized FOXA2 binding at a subset of potential sites, the presence of additional factors may be required to establish robust FOXA2 occupancy. It will be interesting to investigate how other TFs (including nonpioneer factors), as well as modulations to cofactor motif sequences at particular loci, affect pioneer-factor occupancy.
The interaction of FOXA2 with repressors may possibly explain the limited gain in DNA accessibility observed at most target sites 7, 39, 40 . Yet sites that substantially gained accessibility generally also gained modest enrichment of phased and modified histones, potentially indicating recruitment of the ATP-dependent chromatin-remodeling machinery to this subset of target sites. Additionally, FOXA2 may specifically displace linker histone H1 at this subset of regions, which could also increase accessibility 3 .
Mechanistic investigations into the loss of methylation observed at some FOXA2 targets uncovered a dependence on DNA replication, because cells arrested in G 1 did not dynamically lose DNAme despite occupancy and changes to DNA accessibility. Our study suggests that S-phase binding of FOXA2 may occur rapidly after nascent-strand synthesis and before maintenance methylation. The proximity of CpG dinucleotides to the FOXA2 peak summit is a distinguishing characteristic of targets that become demethylated, supporting a model in which occupancy directly interferes with the DNAme machinery. A recent study has speculated that loss of DNAme at FOXA1 targets may result from an active demethylation mechanism involving DNA-repair enzymes 41 , although that study did not examine DNAme loss in the absence of DNA replication or report the active demethylating enzyme. Therefore, alternative possibilities remain, and more work must be done to clarify the molecular pathway that leads to the removal of this modification. Our data show a clear requirement for DNA replication in the dynamic loss of DNAme, but we cannot rule out the possibility of an enzymatic pathway, such as TET-mediated hydroxymethylation, that either blocks maintenance or marks methylated cytosines for removal following replication. Together, the systematic comparison of endogenous and ectopic TF behaviors reveals relevant mechanistic details and provides more comprehensive understanding of pioneer factors, supporting their rational application toward cellular reprogramming.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41588-017-0034-3. replicate separately. For MACS2 peak calling, we used corresponding whole cell extract (WCE) as a background control and a P-value cutoff of 0.01. This initial peak calling using IDR and MACS2 resulted in a set of peaks that were above background for each cell type. As an additional filtering method and to facilitate comparison of peaks from different cell types and conditions, we developed an in-house computational framework to redefine relative peak positions and to standardize peak width. We merged IDR-called peaks from all cell types if they overlapped by at least 20%, while keeping track of the summits of the peaks being merged. This procedure resulted in a master peak set encompassing all FOXA2 datasets. Because several peaks with different peak summits were merged, we devised a simple weighted framework to define new peak summits. To assign a new peak summit, we used the peak height as a measure of weighed distance from the peak center. Using this weighted measure of peak height, we calculated a new peak summit, which was closest to the highest peak that was merged but also represented contributions from smaller peaks in a distance-dependent manner. All peaks were assigned new peak summits by using this formula. To define new peak widths, we extended each peak by 300 bp in both directions from the peak summit to have all peaks of 600 bp. Enrichment of different histone marks at these FOXA2 peaks was calculated with the standard RPKM formula.
Composite plots. Composite plots showing enrichment of different histone marks at FOXA2 peaks were made in the HOMER package 47 . As described in the HOMER documentation, we first created tag directories for each sample or histone mark that we wished to plot around peak regions. Peaks were extended by 2,000 bp in each direction, and tag directories were then used to create a matrix with tag densities at each nucleotide and each individual replicate was normalized for its respective sequencing depth. Matrix files with the tag density at each position within an extended 4,000-bp window were imported into R to create the plots.
Read-density heat maps.
Read-density heat maps were created with the EnrichedHeatmap (https://github.com/jokergoo/EnrichedHeatmap/) and ComplexHeatmap (https://github.com/jokergoo/ComplexHeatmap/) packages. We first determined the genome-wide coverage of each sample or histone mark by using coverageBed from the BEDTools package 49 . These coverage files and the peak regions to be plotted were supplied as input to ComplexHeatmap. The heat in each heat map was decided on the basis of the percentile range by capping the maximum at the ninety-ninth percentile to remove outliers. Differential motif analysis. Differential motif analysis was performed in HOMER 47 . To calculate differential enrichment between two sets of peaks, we used one set as background and then interchanged to calculate for another set. The motifs were scanned in 200-bp regions around the peak center in both directions.
Epigenetic-state maps. To classify FOXA2-bound regions in different chromatin states, we used a hierarchical classification system. First, all FOXA2 peaks that had ATAC-seq (RPKM >3) enrichment were classified as accessible. Next, peaks that had either H3K27ac or H3K4me1 (RPKM >3) were marked as 'active' , and regions with H3K27me3 or H3K9me3 (RPKM >3) were classified as 'repressed' . After classifying all histone modifications, we divided the rest of the regions on the basis of their DNAme levels. Regions with DNAme levels below 20% were marked as lowly methylated regions (LMR), regions with methylation levels between 20% and 60% were called intermediately methylated regions (IMR), and regions with methylation levels above 60% were termed highly methylated regions (HMR).
ChIP-BS-seq analysis.
For the analysis of methylation changes associated with FOXA2 binding, we redefined binding sites to maximize overlap with our ChIP-BS-seq data, because bisulfite conversion on small amounts of input DNA results in material loss. To do so, we combined FOXA2 ChIP-seq data from BJ FOXA2 cells 4 d and 10 d after induction. The summit of each peak was determined in MACS, the region 200 bp to either side was then selected, and overlapping regions were merged to generate a list of 113,398 sites. We then intersected these regions with BJ-fibroblast WGBS and 4-d BJ FOXA2 ChIP-BS-seq datasets and selected only CpGs covered by at least three reads in both samples, thus yielding a total of 42,086 sites and 135,785 CpGs. We used these same regions to select matched CpGs covered at ≥3× in the ChIP-BS-seq data from the BJ FOXA2 mimosine-treated and released samples (n = 13,494 sites and 18,429 CpGs). For analysis of BJ FOXA2-CDT1 , we considered only regions that were 10× covered. We compared individual CpG and mean FOXA2-binding-site methylation, generated CpG counts and coverage plots, and calculated the distances between the summit and the nearest CpG by using custom R scripts. For comparison to the ATAC-seq data (described above), we used HOMER 47 to generate enrichment composite plots for 2 kb to either side of the peaks. Corresponding author(s): Alexander Meissner
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